Navigation Links
Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study

n pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

# # #

Novartis Media Relations

Corinne Hoff Novartis Global Media Relations +41 61 324 9577 (direct) +41 61 324 2200 (main) corinne.hoff@novartis.com

Gloria Stone Novartis Oncology Media Relations +1 862 778-5587 (direct) gloria.stone@novartis.com

e-mail: media.relations@novartis.com

Novartis Investor Relations

International: Ruth Metzler-Arnold +41 61 324 7944 Katharina Ambühl +41 61 324 5316 Nafida Bendali +41 61 324 3514 Jason Hannon +41 61 324 2152 Thomas Hungerbuehler +41 61 324 8425 Richard Jarvis +41 61 324 4353

North America: Ronen Tamir +1 212 830 2433 Arun Nadiga +1 212 830 2444 Jill Pozarek +1 212 830 2445 Edwin Valeriano +1 212 830 2456

e-mail: investor.relations@novartis.com

[*]Known as Gleevec® (imatinib mesylate) tablets in the U.S., Canada and Israel.


'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

Post Your Comments:
(Date:11/9/2009)...swire/ -- Celling Technologies, a subsidiary of Sp...nesis, Inc. to research potential applications for...ith acquired the global rights in spine for Tissue...echnology in November of 2007. Replacing the prio... Celling Technologies to further research adipose ...
(Date:11/9/2009)...RNewswire/ -- Women,s sexual health company, TivaM...eve as it prepares for a 2010 launch of its Viveve...Viveve is a name that we believe captures the esse..." said Kerry Pope, Viveve,s president and chief ex...lping women restore their sense of fulfillment and...
(Date:11/9/2009)...ewswire/ -- Access MediQuip, LLC, the nation,s fir...medical device management solutions to the healthc...g its corporate headquarters to Lake Mary, Florida...d growth, includes a major expansion of the Primer...anuary 2010 and relocation and expansion of the Ho...
Breaking Medicine Technology:Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 3Women's Sexual Health Company Changes Name in Preparation for Market Entry 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Perfect Fitness Ranks No 1 of Consumer Product Companies on 2009 Inc 500 List Ranks No 4 Overall 54327 1Perfect Fitness Ranks No 1 of Consumer Product Companies on 2009 Inc 500 List Ranks No 4 Overall 54327 2Verizon Wireless Offers Healthy Applications to Turn a Mobile Phone Into a Personal Trainer 54323 1Verizon Wireless Offers Healthy Applications to Turn a Mobile Phone Into a Personal Trainer 54323 2BioNeutrals Ygiene 28TM 29 Achieves Worlds Fastest Kill Time With a 100 25 Total Spore Eradication Verified In Independent Sporicidal Sterilant Test 54319 1BioNeutrals Ygiene 28TM 29 Achieves Worlds Fastest Kill Time With a 100 25 Total Spore Eradication Verified In Independent Sporicidal Sterilant Test 54319 2BioNeutrals Ygiene 28TM 29 Achieves Worlds Fastest Kill Time With a 100 25 Total Spore Eradication Verified In Independent Sporicidal Sterilant Test 54319 3BioNeutrals Ygiene 28TM 29 Achieves Worlds Fastest Kill Time With a 100 25 Total Spore Eradication Verified In Independent Sporicidal Sterilant Test 54319 4
...itive Phase II Results of Roche and Ipsen,s First ...can Diabetes Association Meeting -, NUTLEY, N.J.,... diabetes drug taspoglutide (R1583) has been shown...ntrol and weight loss after only,eight weeks of tr...e that,supports entry into Phase III. Taspoglutide...
...AIN VIEW, Calif., June 9 Alexza,Pharmaceuticals, ...results,from its Phase 2a proof-of-concept clinica...tients with panic disorder. The study did not meet...of AZ-002 on the incidence of a,doxapram-induced p...on of a,doxapram-induced panic attack, both as com...
Other Medicine Technology:Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 2Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 3Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 4Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 6Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 2Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 3Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 4
(Date:11/9/2009)...ion backs President Obama,s promise to not expand ... ,, Bishops still concerned for poor, elderly ...-- Cardinal Francis George of Chicago, president o..., lauded the November 7 decision of the U.S. House...eform money from paying for elective abortions. ,...
(Date:11/9/2009)...ports success with drugs that inhibit estrogen, ,...o drugs used to treat breast cancer and osteoporos...o a new study. , The drugs also cleared precanc...ted the onset of cancer in mice with precancerous ...nd the breast cancer/osteoporosis drug raloxifene ...
(Date:11/9/2009)...n and women almost equally, study finds, , ...y used clot-dissolving drug Plavix (clopidogrel) w...s of major clinical trials has found. , "After ...ing both men and women with this very important dr...ovascular thrombosis at New York University Langon...
(Date:11/9/2009)... Networking is everybody,s buzz word toda...StaffingClub.com enables Recruiters and Staffers c...nect, share, communicate and close positions. The ...heir profiles and network with recruiters. , ...rrent Job Market forces everyone to network more t...
(Date:11/9/2009)...ve letter formation could boost self-esteem, resea... News) -- Autistic children are more likely to hav...letters, than those without autism, researchers sa... to 13. Half of the study participants had autism ...within the normal range for perceptual reasoning o...
Breaking Medicine News(10 mins):Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:Handwriting Skills May Lag in Kids With Autism 2
...g 15 pounds or more over several years puts one at...are obese but maintain a stable weight . Resea... and 30 over 15 years. Most participants gained 15...s. But only 4 percent of those who didn't gain the...
...in optimum cardiovascular health can not only affe...rs .// Researchers say they have found a link ...or cognitive impairment in the elderly. The condit...ls of High Density Lipoprotein . During a span ...
...l tissue, which is normally found only in the lini... attaches itself to ligaments and organs in the ab...mptoms include pain, bleeding, inflammation, adhes...rs studied 133 women with endometriosis and a cont...
...ay be a strong link between Skin Allergies and can... may actually be more prone //to blood related can...ers reported this finding in a study in the recent...kemia and those of us who have as children suffer...
...ple researchers say dads who have children at an o...veloping schizophrenia later in life. Research...mitted to the hospital in Sweden between 1989 and ... conception and their children's risk of becoming ...
...s for viral RNA among organ and tissue donors who ...se // transmission among transplant recipients, sa...r the presence of blood antibodies to diseases suc...mune response. For the study 2,236 organ donors...
Other Medicine News:
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: